About BioKinetic Europe
BioKinetic Europe was a Healthcare company based in Belfast (United Kingdom) founded in 1996. It serves as a CRO providing phase I-III clinical development and adaptive trial design services. It operates on a B2B model. The company is recorded as dissolved. Its focus areas include Biotechnology, Clinical Research and Trial Design.
Company details
BioKinetic Europe, established in 1996 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, clinical research, and trial design. Serves as a CRO providing phase I-III clinical development and adaptive trial design services. Adapting to market demands with innovation and client-focused strategies.
- Headquarters Belfast, United Kingdom
- SectorsHealthcare
- Website ww25.biokineticeurope.com/?subid1=20250319-1841-445d-b3b4-297abcd1de09
- Social X Facebook
Web traffic of BioKinetic Europe
Websites that share an audience with BioKinetic Europe (biokineticeurope.com).
Websites whose visitors overlap most with BioKinetic Europe. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| biotrial.com | 99% | 8.3K | #3,598,221 | View details |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BioKinetic Europe
BioKinetic Europe was founded in 1996.
BioKinetic Europe is headquartered in Belfast, United Kingdom. It is registered at Belfast, Northern Ireland, United Kingdom.
BioKinetic Europe, established in 1996 and currently in Dissolved stage, focuses on providing healthcare solutions, advancing biotech innovations, clinical research, and trial design. Serves as a CRO providing phase I-III clinical development and adaptive trial design services. Adapting to market demands with innovation and client-focused strategies.